Med-X, Inc. Announces Qualification To Sell Securities Through Regulation A+ Equity Crowdfunding

Move Marks First Cannabis Industry Company to Offer Investment Opportunity to the General Public

Nov 17, 2015, 04:20 ET from Med-X, Inc.

LOS ANGELES, Nov. 17, 2015 /PRNewswire/ -- Med-X, Inc. (Med-X) today announced that it has been qualified by The Securities and Exchange Commission (SEC) to sell shares to the general public through its Regulation A+ equity crowdfunding initiative as the next phase in the company's fundraising strategy. Med-X is the first company in the cannabis industry to be qualified by the SEC for a public offering under these rules. This offering will present an enticing and unique opportunity for anyone interested in investing in the burgeoning cannabis industry, which is expected to yield billions in revenue annually.

In an unprecedented development in March 2015, the SEC finalized rules under Title IV of the 2012 Jumpstart Our Business Startups (JOBS) Act, paving the way for private companies to raise up to $50 million from non-accredited investors. This new ruling is known as Regulation A+, and it allows everyday Americans to invest in private companies such as Med-X.

With an eye toward the future, Med-X is developing several divisions: media information network, research & development, agriculture and manufacturing for the expanding medical and recreational cannabis industry. The company's relationships in the medical and biochemistry fields give it the ability to position itself as a long-term player in the industry. Med-X has engaged CrowdfundX, a leading crowdfunding agency, to manage their equity crowdfunding campaign, which will be launched on the StartEngine platform. 

"We are honored to be recognized as a leader in the cannabis industry, and are pleased to be engaging with StartEngine and CrowdfundX on the new Reg A+ Crowdfunding platform," said Dr. David Toomey, CEO of Med-X.

In February 2015, Med-X opened its first facility to cultivate 100% natural and organically grown medical marijuana for its research & development program. Med-X's management recognized a huge need to bring medical marijuana to the medical community that is free of pesticides, mold, and other harmful substances. It is important to know that today, the cultivation quality of medical marijuana being distributed nationally through a wide range of dispensaries is not regulated.

Individuals interested in learning more about the Med-X investment opportunity can go to StartEngine.com. Med-X will be one of the first ten companies utilizing StartEngine.com.

SEC Disclaimer
The United States Securities and Exchange Commission does not pass upon the merits of or give its approval to any securities offered or the terms of the Offering, nor does it pass upon the accuracy or completeness of any Offering circular or other selling literature. These securities are offered pursuant to an exemption from registration with the Commission; however, the Commission has not made an independent determination that the securities offered hereunder are exempt from registration.

About Med-X, Inc.
Med-X, Inc. is a Nevada corporation formed in February 2014 to cultivate and support the fast paced emerging Cannabis industry through such activities as compound identification and extraction of the identified Cannabidiol (CBD) compounds for the present medical industry demand. The Company also plans to create and publish high quality Cannabis industry media content through the Company's online media platform, www.marijuanatimes.org to generate revenue from advertisers as well as sell industry related merchandise to patients and consumers. The Company is also gearing up to supply products to the Cannabis agricultural and provisioning industries through manufacturing partnerships. For more information regarding Med-X, please visit www.medx-rx.com, email info@medx-rx.com or call 818-349-2870.

About CrowdfundX
CrowdfundX is a pioneering crowdfunding agency serving corporations and entrepreneurs  across a wide mix of industries. The company helps clients to effectively architect and execute strategic equity and rewards-based crowdfunding campaigns that build brand equity and drive growth. CrowdfundX regularly oversees comprehensive campaigns for multinational corporations, VCs and entrepreneurs alike including XTI Aircraft, Elio Motors, Inventure Holdings, K2 Communications, XREAL, and SURKUS. For more information regarding CrowdfundX, visit www.crowdfundx.io.

About StartEngine Crowdfunding, Inc.
StartEngine is the premier equity crowdfunding platform, connecting entrepreneurs and aspiring investors with tomorrow's progressive companies. Based in Los Angeles, the company was created in 2013 by Howard Marks, co-founder of Activision, and Ron Miller. StartEngine aims to revolutionize the startup business model by helping individuals invest in private companies on a public platform for the first time in history, thereby helping entrepreneurs achieve their dreams. Learn more at http://www.startengine.com.

Forward Looking Statement
"This release may contain forward looking statements regarding predicted business performance, operating results, financial condition and other aspects of the Company, expressed by such language as "expected", "anticipated", "projected" and "forecasted."  Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward looking statements will actually be realized by the Company.  Forward looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events."

Media Contact:

Grant Harvey


grant@crowdfundx.io


805-698-5122

 

SOURCE Med-X, Inc.



RELATED LINKS

http://www.medx-rx.com